Despite the significant correlations of WAC-AS1 with TMB and MSI, the correlation coefficients across all types of cancers were less than 0.5, suggesting that WAC-AS1 expression may not be used as an independent predictor for patients’ response to ICBs. Here, WAC-AS1 is linked to cancer.